Tesla Labs Private Limited logo

Tesla Labs Private Limited

Manufactures and sells ayurvedic, homeopathic, and allopathic drugs and medicines.
2019 | Pune, Maharashtra (India) | Active

Last Updated:

November 16, 2024
HomeCompanyTesla Labs Private Limited

Who are the key members and board of directors at Tesla Labs?

Executive Team (1)

NameDesignationAppointment DateStatus
Prateek Ostawal InManaging Director11-Jun-2019Current

Board Members(1)

NameDesignationAppointment DateStatus
Navani Runwal In Whole-Time Director 15-Dec-2022Current

Financial Performance of Tesla Labs.

Tesla Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.63% increase. The company also saw a substantial improvement in profitability, with a 100.1% increase in profit. The company's net worth Soared by an impressive increase of 162.47%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
102.63%
Revenue from Operations
102.63%
Total Assets
116.37%
Profit or Loss
100.10%
Net Worth
162.47%
EBITDA
128.64%

Charges (Loans)

Open Charges

₹50.00 M

LenderAmountStatus

Others

Creation Date: 21 Dec 2023
₹5.00 CrOpen

How Many Employees Work at Tesla Labs?

Unlock and access historical data on people associated with Tesla Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Tesla Labs

Recent activity within the organization

  • Annual General Meeting

    Tesla Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Tesla Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.

    31 Mar 2024

  • Charges

    A charge with Others amounted to Rs. 50.00 M with Charge ID 100845340 was registered on 21 Dec 2023.

    21 Dec 2023

  • Director Appointment

    Navani Pradeep Runwal was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 15 Dec 2022 & has been associated with this company since 2 years 7 days .

    15 Dec 2022

  • Director Appointment

    Prateek Ostawal was appointed as a Managing Director was appointed as a Managing Director on 11 Jun 2019 & has been associated with this company since 5 years 6 months .

    11 Jun 2019

  • Company Incorporation

    Tesla Labs Private Limited was registered on 11 Jun 2019 with Roc Pune & aged 5 years 6 months as per MCA records.

    11 Jun 2019

Frequently asked questions

  • Tesla Labs Private Limited was incorporated on 11 Jun 2019.

  • The authorized share capital of Tesla Labs Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.

  • Currently 2 directors are associated with Tesla Labs Private Limited.

    • Navani Pradeep Runwal
    • Prateek Ostawal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Tesla Labs Private Limited is 41/12 Erandavana Office No.4 Karve Road, Basement India, Pune, Maharashtra, 411004.

  • The corporate identification number (CIN) of Tesla Labs Private Limited is U51397PN2019PTC184704 and the company number is 184704 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Tesla Labs Private Limited is https://www.teslalabs.in

  • According to the financial reports for the fiscal year 2023, the revenue trend for Tesla Labs Private Limited has risen by 102.63%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Tesla Labs Private Limited has experienced an upsurge of 162.47%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Tesla Labs Private Limited amount to ₹ 5.00 Cr.

  • The most recent Balance Sheet for Tesla Labs Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development